Skip to main content
SpringerLink
Log in

Drug-Induced Uveitis

  • Chapter
Intraocular Inflammation

  • 234 Accesses

Abstract

Drugs can induce uveitis by direct or indirect mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Abdi EA, Nguyen GK, Ludwig RN et al (1987) Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma. Cancer 59:896–900

    Article  CAS  PubMed  Google Scholar 

  2. Akingbehin AO (1993) Granulomatous uveitis and metipranolol – replay. Br J Ophthalmol 77:536–537

    Article  Google Scholar 

  3. Akingbehin T, Villada JR (1991) Metipranolol-associated granulomatous anterior uveitis. Br J Ophthalmol 75:519–523

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Akingbehin T, Villada JR, Walley T (1992) Metipranolol-induced adverse reactions. I. The rechallenge study. Eye 6:277–279

    Article  PubMed  Google Scholar 

  5. Ambati J, Wynne KB, Angerame MC et al (1999) Anterior uveitis associated with intravenous cidofovir use in patients with cytomegalovirus retinitis. Br J Ophthalmol 83:1153–1158

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Antonopoulos C, Stem M, Comer GM (2011) Acute anterior uveitis following intravitreal bevacizumab but not subsequent ranibizumab. Clin Ophthalmol 5:1659–1662

    PubMed Central  CAS  PubMed  Google Scholar 

  7. Bainbridge JW, Raina J, Shah SM et al (1999) Ocular complications of intravenous cidofovir for cytomegalovirus retinitis in patients with AIDS. Eye 13:353–356

    Article  PubMed  Google Scholar 

  8. Bakri SJ, Larson TA, Edwards AO (2008) Intraocular inflammation following intravitreal injection of bevacizumab. Graefes Arch Clin Exp Ophthalmol 246:779–781

    Article  CAS  PubMed  Google Scholar 

  9. Banker AS, Arevalo JF, Munguia D et al (1997) Intraocular pressure and aqueous humor dynamics in patients with AIDS treated with intravitreal cidofovir for cytomegalovirus retinitis. Am J Ophthalmol 124:168–180

    Article  CAS  PubMed  Google Scholar 

  10. Beck RW, Moke P, Blair RC et al (1996) Uveitis associated with topical beta-blockers. Arch Ophthalmol 115:1181–1182

    Article  Google Scholar 

  11. Becker H, Walton RC, Diamant JI et al (2004) Anterior uveitis and concurrent allergic conjunctivitis associated with long-term use of topical 0.2% brimonidine tartrate. Arch Ophthalmol 122:1063–1066

    Article  PubMed  Google Scholar 

  12. Bhagat N, Read RW, Rao NA et al (2001) Rifabutin-associated hypopyon uveitis in human immunodeficiency virus-negative immunocompetent individuals. Ophthalmology 201:750–752

    Article  Google Scholar 

  13. Boyer DS, Heier JS, Brown DM et al (2009) A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration. Ophthalmology 116:1731–1739

    Article  PubMed  Google Scholar 

  14. Brown DM, Campochiaro PA, Bhisitkul RB et al (2011) Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology 118:1594–1602

    Article  PubMed  Google Scholar 

  15. Byles DB, Frith P, Salmon JF (2000) Anterior uveitis as a side effect of topical brimonidine. Am J Ophthalmol 130:287–291

    Article  CAS  PubMed  Google Scholar 

  16. Campochiaro PA, Brown DM, Awh CC et al (2011) Sustained benefits from ranibizumab for macular oedema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology 118:2041–2049

    Article  PubMed  Google Scholar 

  17. Camras CB, Alm A, Watson P (1996) Latanoprost, a prostaglandin analogue, for glaucoma therapy: efficacy and safety after 1 year of treatment in 198 patients. Ophthalmology 103:1916–1924

    Article  CAS  PubMed  Google Scholar 

  18. Cellini M, Caramazza R, Bonsanto D et al (2004) Prostaglandin analogs and blood-aqueous barrier integrity: a flare cell meter study. Ophthalmologica 218:312–317

    Article  CAS  PubMed  Google Scholar 

  19. Chang JH, McClusky P, Missotten T et al (2008) Use of ocular hypotensive prostaglandin analogues in patients with uveitis: does their use increase anterior uveitis and cystoid macular oedema? Br J Ophthalmol 92:916–921

    Article  CAS  PubMed  Google Scholar 

  20. Chavez-de la Paz E, Arevalo JF, Kirsch LS et al (1997) Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention. Ophthalmology 104:539–544

    Article  CAS  PubMed  Google Scholar 

  21. Davis JL, Taskintuna I, Freeman WR et al (1997) Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis. Arch Ophthalmol 115:733/737

    Article  Google Scholar 

  22. Deuter CM, Kötter I, Günaydin I et al (2003) Behcet’s disease: visual acuity after 5 years in patients with alpha-interferon treatment. Adv Exp Mol Biol 528:525–528

    Article  CAS  Google Scholar 

  23. Doycheva D, Deuter C, Stuebiger N et al (2009) Interferon-alpha-associated presumed ocular sarcoidosis. Greafes Arch Clin Exp Ophthalmol 247:675–680

    Article  CAS  Google Scholar 

  24. Eakins KE, Whitelocke RAF, Bennet A (1972) Prostaglandin-like activity in ocular inflammation. Br Med J 3:452–453

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Fechtner RD, Khouri AS, Zimmerman TJ et al (1998) Anterior uveitis associated with latanoprost. Am J Ophthalmol 126:37–41

    Article  CAS  PubMed  Google Scholar 

  26. Fietta P, Manganelli P, Lodigiani L (2003) Clodronate induced uveitis. Ann Rheum Dis 62:378

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Fineman MS, Vander J, Regillo CD et al (2001) Hypopyon uveitis in immunocompetent patients treated for Mycobacterium avium complex pulmonary infection with rifabutin. Retina 21:531–533

    Article  CAS  PubMed  Google Scholar 

  28. Fleisch H (1991) Bisphosphonates: pharmacology and use in the treatment of tumor-induced hypercalcaemia and metastatic bone disease. Drugs 42:919–944

    Article  CAS  PubMed  Google Scholar 

  29. Fonollosa A, Segura A, Girald J et al (2007) Tuberculosis uveitis after treatment with etanercept. Greafes Arch Clin Exp Ophthalmol 245:1397–1399

    Article  CAS  Google Scholar 

  30. Fraunfelder FW, Rosenbaum JT (1997) Drug-induced uveitis. Drug Saf 17:197–207

    Article  CAS  PubMed  Google Scholar 

  31. Fraunfelder FW, Suhler EB, Fraunfelder FT (2010) Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reports. Cutan Ocul Toxicol 29:26–29

    Article  PubMed  Google Scholar 

  32. Fung AE, Rosenfeld PJ, Reichel E (2006) The international intravitreal bevacizumab safety survey: using the internet to assess dug safety worldwide. Br J Ophthalmol 90:1344–1349

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  33. Georgopoulos M, Polak K, Prager F et al (2009) Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin). Br J Ophthalmol 93:457–462

    Article  CAS  PubMed  Google Scholar 

  34. Goyal R, Ram AR (2000) Brimonidine tartrate 0.2% (Alphagan) associated granulomatous anterior uveitis. Eye 14:908–910

    Article  CAS  PubMed  Google Scholar 

  35. Greene BM, Taylor HR, Brown EJ et al (1981) Ocular and systemic complications of diethylcarbamazine therapy for onchocerciasis: association with circulating immune complexes. J Infect Dis 147:890–897

    Article  Google Scholar 

  36. Guyer DR, Tiedeman J, Yannuzzi LE et al (1993) Interferon associated retinopathy. Arch Ophthalmol 111:350–356

    Article  CAS  PubMed  Google Scholar 

  37. Hashkes PJ, Shajrawi I (2003) Sarcoid-related uveitis occurring during etanercept therapy. Clin Exp Rheumatol 21:645–646

    CAS  PubMed  Google Scholar 

  38. Hayasaka S, Nagaki Y, Matsumoto M et al (1998) Interferon associated retinopathy. Br J Ophthalmol 82:323–325

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Hinkle DM, Decey MS, Mandelcorn E et al (2012) Bilateral uveitis associated with fluoroquinolone therapy. Cutan Ocul Toxicol 31:111–116

    Article  CAS  PubMed  Google Scholar 

  40. Hirano A, Kataoka M, Nakata Y et al (2005) Sarcoidosis occurring after interferon-alpha therapy for chronic hepatitis C: report of two cases. Respirology 10:529–534

    Article  PubMed  Google Scholar 

  41. Islam SM, El-Sheikh HF, Tabbara KF (2000) Anterior uveitis following combined vaccination for measles, mumps and rubella (MMR): a report of two cases. Acta Ophthalmol Scand 78:590–592

    Article  CAS  PubMed  Google Scholar 

  42. Jacobs DS, Piliero PJ, Kuperwasser MG et al (1994) Acute uveitis associated with rifabutin use in patients with human immunodeficiency virus infection. Am J Ophthalmol 118:716–722

    Article  CAS  PubMed  Google Scholar 

  43. Jain S (1994) Betaxolol-associated anterior uveitis. Eye 8:708–709

    Article  PubMed  Google Scholar 

  44. Jambol LM (1985) Aphakic cystoid macular edema: a hypothesis. Arch Ophthalmol 103:1134–1135

    Article  Google Scholar 

  45. Jarrett SJ, Cunnane G, Conaghan PG et al (2003) Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series. J Rheumatol 30:2287–2291

    PubMed  Google Scholar 

  46. Jonas JB, Kreissig I, Spandau UH et al (2006) Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide. Am J Ophthalmol 141:579–580

    Article  CAS  PubMed  Google Scholar 

  47. Jonasch E, Haluska FG (2001) Interferon in oncological practice: review of interferon biology, clinical applications and toxicities. Oncologist 6:34–55

    Article  CAS  PubMed  Google Scholar 

  48. Jonisch J, Lai JC, Deramo VA et al (2008) Increased incidence of sterile endophthalmitis following intravitreal preserved triamcinolone acetonide. Br J Ophthalmol 92:1051–1054

    Article  CAS  PubMed  Google Scholar 

  49. Kay CN, Tarantola RM, Gehrs KM et al (2011) Uveitis following intravitreal bevacizumab: a non-infectious cluster. Ophthalmic Surg Lasers Imaging 42:292–296

    Article  PubMed  Google Scholar 

  50. Kempen JH, Yi M, Freeman WR et al (2006) Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology 113:684–694

    Article  PubMed  Google Scholar 

  51. Krupin T, LeBlanc RP, Becker B et al (1970) Uveitis in association with topically administered corticosteroid. Am J Ophthalmol 70:883–885

    Article  CAS  PubMed  Google Scholar 

  52. Ladas ID, Karagiannis DA, Pouvas AA et al (2009) Safety of repeat intravitreal injections of bevacizumab versus ranibizumab. Retina 29:313–318

    Article  PubMed  Google Scholar 

  53. Lim LL, Fraunfelder FW, Rosenbaum JT (2007) Do tumor necrosis factor inhibitors cause uveitis? Arthritis Rheum 56:3248–3252

    Article  CAS  PubMed  Google Scholar 

  54. London NJ, Garg SJ, Moorthy RS et al (2013) Drug-induced uveitis. J Ophthalmic Inflamm Infect 3:43–60

    Article  PubMed Central  PubMed  Google Scholar 

  55. Lopez, Sola E, Gutierrez C et al (2006) Anterior uveitis associated with treatment with intravenous cidofovir in kidney transplant patients with BK virus nephropathy. Transplant Proc 38:2412–2413

    Article  CAS  PubMed  Google Scholar 

  56. Macarol V, Fraunfelder FT (1994) Pamidronate disodium and possible ocular adverse drug reactions. Am J Ophthalmol 118:220–224

    Article  CAS  PubMed  Google Scholar 

  57. Makkonen N, Salminen A, Rogers MJ et al (1999) Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite. Eur J Pharm Sci 8:109–118

    Article  CAS  PubMed  Google Scholar 

  58. Martin DF, Maguire MG, Ying GS (2011) Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364:1897–1908

    Article  CAS  PubMed  Google Scholar 

  59. Martins JC, Wilensky JT, Asseff CF et al (1974) Corticosteroid-induced uveitis. Am J Ophthalmol 77:433–437

    Article  CAS  PubMed  Google Scholar 

  60. Melles RB, Wong IG (1994) Metipranolol-associated granulomatous iritis. Am J Ophthalmol 118:712–715

    Article  CAS  PubMed  Google Scholar 

  61. Moorthy RS, Valluri S, Jampol LM (1998) Drug-induced uveitis. Sur Ophthalmol 42:557–570

    Article  CAS  Google Scholar 

  62. Moshfeghi DM, Kaiser PK, Scott IU et al (2003) Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 136:791–796

    Article  CAS  PubMed  Google Scholar 

  63. Moshfeghi AA, Scott IU, Flynn HW Jr et al (2004) Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema. Am J Ophthalmol 138:489–492

    Article  CAS  PubMed  Google Scholar 

  64. Nagaoka T, Sato E, Takabashi A et al (2007) Retinal circulatory changes associated with interferon-induced retinopathy in patients with hepatitis C. Invest Ophthalmol Vis Sci 48:368–375

    Article  PubMed  Google Scholar 

  65. Nelson ML, Tennant MTS, Sivalingam A et al (2003) Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 23:686–691

    Article  PubMed  Google Scholar 

  66. Nguyen EV, Azap D, Papalkar D et al (2008) Brimonidine-induced anterior uveitis and conjunctivitis: clinical and histological feature. J Glaucoma 17:40–42

    Article  PubMed  Google Scholar 

  67. O’Conner GR (1993) Granulomatous uveitis and metipranolol. Br J Ophthalmol 77:536–538

    Article  Google Scholar 

  68. Olsen NJ (2004) Drug-induced autoimmunity. Best Pract Res Clin Rheumatol 18:677–688

    Article  CAS  PubMed  Google Scholar 

  69. Parronchi P, Mohapatra S, Sampognaro S et al (1996) Effects of interferon-alpha on cytokine profile, T cell receptor repertoire and peptide reactivity of human allergic-specific T cells. Eur J Immunol 26:697–703

    Article  CAS  PubMed  Google Scholar 

  70. Pichler WJ (2003) Drug-induced autoimmunity. Curr Opin Allergy Clin Immunol 3:249–253

    Article  CAS  PubMed  Google Scholar 

  71. Pichler WJ (2006) Adverse side-effects to biological agents. Allergy 61:912–920

    Article  CAS  PubMed  Google Scholar 

  72. Ramos-Casals M, Mana J, Nardi N et al (2005) Sarcoidosis in patients with chronic hepatitis C virus infection. Analysis of 68 cases. Medicine 84:69–80

    Article  CAS  PubMed  Google Scholar 

  73. Reddy AR, Backhouse OC (2003) Does etanercept induce uveitis? Br J Ophthalmol 87:925

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  74. Rosenfeld PJ, Brown DM, Heier JS et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431

    Article  CAS  PubMed  Google Scholar 

  75. Roth DB, Chieh J, Spirn MJ et al (2003) Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 121:1279–1282

    Article  PubMed  Google Scholar 

  76. Salmen S, Berrueta L, Sanchez N et al (2002) Nongranulomatous anterior uveitis associated with alendronate therapy. Invest Clin 43:49–52

    PubMed  Google Scholar 

  77. Saran BR, Maguire AM, Nichols C et al (1994) Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin. Arch Ophthalmol 112:1159–1165

    Article  CAS  PubMed  Google Scholar 

  78. Sato T, Emi K, Ikeda T et al (2010) Severe intraocular inflammation after intravitreal injection of bevacizumab. Ophthalmology 117:512–516

    Article  PubMed  Google Scholar 

  79. Saurenmann RK, Levin AV, Feldman BM et al (2006) Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFα agents. J Pediatr 149:833–836

    Article  CAS  PubMed  Google Scholar 

  80. Schmeling H, Horneff G (2005) Etanercept and uveitis in patients with juvenile idiopathic arthritis. Rheumatology 44:1008–1011

    Article  CAS  PubMed  Google Scholar 

  81. Shafran SD, Deschenes J, Miller M et al (1994) Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin and ethambutol. N Engl J Med 330:438–439

    Article  CAS  PubMed  Google Scholar 

  82. Skolik S, Willermain F, Caspers LE (2005) Rifabutin-associated panuveitis with retinal vasculitis in pulmonary tuberculosis. Ocul Immunol Inflamm 13:483–485

    Article  PubMed  Google Scholar 

  83. Smith SL, Pruitt CA, Sine CS et al (1999) Latanoprost 0.005% and anterior segment uveitis. Acta Ophthalmol Scand 77:668–672

    Article  CAS  PubMed  Google Scholar 

  84. Song MK, Azen SP, Bully A et al (2003) Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis. Am J Ophthalmol 136:696–702

    Article  PubMed  Google Scholar 

  85. Spratt A, Key T, Vivian AJ (2008) Chronic anterior uveitis following bacilli Calmette-Guerin vaccination: molecular mimicry in action? J Pediatr Ophthalmol Strabismus 45:252–253

    Article  PubMed  Google Scholar 

  86. Springuel P, McMorran M (2003) Bisphosphonates and ocular disorders. Can Adv React Newsl 13:1–2

    Google Scholar 

  87. Stack R, Tarr K (2006) Drug-induced optic neuritis and uveitis secondary to bisphosphonates. N Z Med J 119:U1888

    PubMed  Google Scholar 

  88. Sutter FK, Gilies MC (2004) Pseudo-endophthalmitis after intravitreal triamcinolone acetonide injection for cystoid macular edema. Am J Ophthalmol 138:489–492

    Article  CAS  Google Scholar 

  89. Taban M, Dupps WJ, Mandell B et al (2006) Etanercept (enbrel)-associated inflammatory eye disease: case report and review of the literature. Ocul Immunol Inflamm 14:145–150

    Article  PubMed  Google Scholar 

  90. Taban M, Singh RP, Chung JYH et al (2007) Sterile endophthalmitis after intravitreal triamcinolone: a possible association with uveitis. Am J Ophthalmol 144:50–54

    Article  CAS  PubMed  Google Scholar 

  91. Tiebaud D, Sauty A, Burckhardt P et al (1997) An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. Calcif Tissue Int 61:386–392

    Article  Google Scholar 

  92. Tilden ME, Rosenbaum JT, Fraunfelder FT (1991) Systemic sulfonamides as a cause of bilateral, anterior uveitis. Arch Ophthalmol 109:67–69

    Article  CAS  PubMed  Google Scholar 

  93. Van Buskirk EM (1980) Adverse reactions from timolol administration. Ophthalmology 87:447–450

    Article  PubMed  Google Scholar 

  94. Vermeire S, Noman M, Van Assche G et al (2003) Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn’s disease: a prospective cohort study. Gastroenterology 62:1168–1177

    Google Scholar 

  95. Von Greyerz S, Bultemann G, Schneyder K et al (2001) Degeneracy and additional alloreactivity of drug-specific human alpha beta (+) T cell clones. Int Immunol 13:877–885

    Article  Google Scholar 

  96. Wang LC, Yang CM (2005) Sterile endophthalmitis following intravitreal injection of triamcinolone acetonide. Ocul Immunol Inflamm 13:295–300

    Article  CAS  PubMed  Google Scholar 

  97. Wendling D, Paccou J, Berthelot JM et al (2011) New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases. Semin Arthritis Rheum 41:503–510

    Article  PubMed  Google Scholar 

  98. Wickremasinghe AA, Michalova K, Gilhotra J et al (2008) Acute intraocular inflammation after intravitreal injections of bevacizumab for treatment of neovascular age-related macular degeneration. Ophthalmology 115:1911–1915

    Article  PubMed  Google Scholar 

  99. Wrawar RE, Bullock JD, Ballal D (1998) Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients. Ophthalmology 105:263–268

    Article  Google Scholar 

  100. Wu L, Martines-Castellanos MA, Quiros-Mercado H et al (2008) Twelve-month safety of intravitreal injections of bevacizumab (AVAstin): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol 246:81–87

    Article  CAS  PubMed  Google Scholar 

  101. Yan KK, Dininhan I, Freiman J et al (2008) Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for hepatitis C. Intern Med J 38:207–210

    Article  CAS  PubMed  Google Scholar 

  102. Yousufzai SY, Abdel-Latif AA (1996) Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species. Exp Eye Res 63:305–310

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center of Ophthalmology, University of Tuebingen, Schleichstr. 12, Tuebingen, 72076, Germany

    Deshka Doycheva & Manfred Zierhut MD, PhD

Authors
  1. Deshka Doycheva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manfred Zierhut MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Deshka Doycheva .

Editor information

Editors and Affiliations

  1. Centre of Ophthalmology, University of Tuebingen, Tuebingen, Germany

    Manfred Zierhut

  2. Biomedical Research Centre, Institute of Ophthalmology, Moorfields Eyes Hospital, Department of Medical Retina, UCL, London, United Kingdom

    Carlos Pavesio

  3. School of Medicine, Department of Ophthalmology, Hokkaido University Graduate, Sapporo, Hokkaido, Japan

    Shigeaki Ohno

  4. University of Belo Horizonte, Belo Horizonte, Brazil

    Fernando Orefice

  5. USC Eye Institute, University of Southern California, Los Angeles, California, USA

    Narsing A. Rao

1 Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Case Report 25

Central serous chorioretinopathy and uveitis (PPT 9091 kb)

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Doycheva, D., Zierhut, M. (2016). Drug-Induced Uveitis. In: Zierhut, M., Pavesio, C., Ohno, S., Orefice, F., Rao, N. (eds) Intraocular Inflammation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-75387-2_155

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-75387-2_155

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-75385-8

  • Online ISBN: 978-3-540-75387-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation